Advanced company searchLink opens in new window

AIMBERRY MEDICAL LIMITED

Company number 10779687

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
10 May 2022 GAZ2 Final Gazette dissolved following liquidation
10 Feb 2022 LIQ13 Return of final meeting in a members' voluntary winding up
16 Jun 2021 LIQ10 Removal of liquidator by court order
21 May 2021 LIQ03 Liquidators' statement of receipts and payments to 16 March 2021
30 Apr 2021 600 Appointment of a voluntary liquidator
30 Mar 2021 LIQ MISC Insolvency:LIQ12 -secretary of state's release of liquidator
11 Feb 2021 CH01 Director's details changed for Anthony Garry Biddle on 9 February 2021
15 May 2020 600 Appointment of a voluntary liquidator
12 May 2020 LIQ01 Declaration of solvency
12 May 2020 RESOLUTIONS Resolutions
  • LRESSP ‐ Special resolution to wind up on 2020-03-17
28 Apr 2020 AD01 Registered office address changed from 55 Upper Tilehouse Street Hitchin Hertfordshire SG5 2EF United Kingdom to 100 st. James Road Northampton NN5 5LF on 28 April 2020
17 Feb 2020 CH01 Director's details changed for Mr Peter Andrew Johns on 1 January 2020
26 Sep 2019 AA Total exemption full accounts made up to 30 June 2019
22 May 2019 CS01 Confirmation statement made on 18 May 2019 with updates
22 Feb 2019 TM01 Termination of appointment of Arthur Thomas Forrest as a director on 8 February 2019
22 Feb 2019 TM01 Termination of appointment of Tarquin Paul Desoutter as a director on 8 February 2019
14 Feb 2019 AA Total exemption full accounts made up to 30 June 2018
11 Jul 2018 SH01 Statement of capital following an allotment of shares on 28 June 2018
  • GBP 222,153.6
05 Jun 2018 PSC07 Cessation of Anthony Garry Biddle as a person with significant control on 21 August 2017
05 Jun 2018 PSC02 Notification of Adelphi Funding Limited as a person with significant control on 21 August 2017
05 Jun 2018 CS01 Confirmation statement made on 18 May 2018 with updates
04 Jun 2018 SH01 Statement of capital following an allotment of shares on 10 May 2018
  • GBP 220,553.6
31 May 2018 RESOLUTIONS Resolutions
  • RES10 ‐ Resolution of allotment of securities
  • RES01 ‐ Resolution of adoption of Articles of Association
14 Mar 2018 AP01 Appointment of Mr Tarquin Paul Desoutter as a director on 13 February 2018
12 Jan 2018 AA01 Current accounting period extended from 31 May 2018 to 30 June 2018